Quantitative multiplexed profiling of cellular signaling networks using phosphotyrosine-specific DNA-tagged SH2 domains

被引:20
作者
Dierck, Kevin
Machida, Kazuya
Voigt, Anja
Thimm, Julian
Horstmann, Martin
Fiedler, Walter
Mayer, Bruce J.
Nollau, Peter
机构
[1] Univ Med Ctr Hamburg Eppendorf, Ctr Clin Pathol, Dept Clin Chem, D-20246 Hamburg, Germany
[2] Univ Connecticut, Ctr Hlth, Beverly Sackler Lab Genet & Mol Med, Dept Genet & Dev Biol, Farmington, CT 06030 USA
[3] Univ Hamburg, Inst Organ Chem, D-20146 Hamburg, Germany
[4] Univ Med Ctr Hamburg Eppendorf, Dept Pediat Hematol & Oncol, D-20246 Hamburg, Germany
[5] Univ Med Ctr Hamburg Eppendorf, Dept Hematol & Oncol, D-20246 Hamburg, Germany
关键词
TYROSINE PHOSPHORYLATION STATE; MASS-SPECTROMETRY; ERBB RECEPTORS; CANCER-CELLS; PROTEINS; TRANSDUCTION; INHIBITORS; LEUKEMIA; BINDING; ABL;
D O I
10.1038/nmeth917
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Deciphering global signaling networks is of great importance for the detailed understanding of cellular signaling processes controlling many important biological functions. Among signaling processes, tyrosine phosphorylation has a central role. At present, adequate techniques for the global characterization of the tyrosine phosphoproteome are lacking, particularly for the analysis of small amounts of protein. By combining the power of PCR amplification with the unique properties of Src homology region 2 (SH2) domains to specifically recognize tyrosine-phosphorylated proteins, we developed a new proteomic approach, termed oligonucleotide-tagged multiplex assay (OTM). For OTM, multiple SH2 domains are labeled by domain-specific oligonucleotide tags, applied as probes to complex protein mixtures in a multiplex reaction and phosphotyrosine-specific interactions are quantified by PCR. Using OTM we reproducibly quantified differential states of tyrosine phosphorylation with high sensitivity and specificity in small amounts of whole cellular extracts as demonstrated for various tumor cell lines and human leukemia samples.
引用
收藏
页码:737 / 744
页数:8
相关论文
共 23 条
[1]   Tyrosine kinase inhibitors: Why does the current process of clinical development not apply to them? [J].
Arteaga, CL ;
Baselga, J .
CANCER CELL, 2004, 5 (06) :525-531
[2]   A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling [J].
Blagoev, B ;
Kratchmarova, I ;
Ong, SE ;
Nielsen, M ;
Foster, LJ ;
Mann, M .
NATURE BIOTECHNOLOGY, 2003, 21 (03) :315-318
[3]   The roles of FLT3 in hematopoiesis and leukemia [J].
Gilliland, DG ;
Griffin, JD .
BLOOD, 2002, 100 (05) :1532-1542
[4]   Signaling - 2000 and beyond [J].
Hunter, T .
CELL, 2000, 100 (01) :113-127
[5]   Protein modification: phosphorylation on tyrosine residues [J].
Hunter, T. .
CURRENT OPINION IN CELL BIOLOGY, 1989, 1 (06) :1168-1181
[6]   ERBB receptors and cancer: The complexity of targeted inhibitors [J].
Hynes, NE ;
Lane, HA .
NATURE REVIEWS CANCER, 2005, 5 (05) :341-354
[7]   Single cell profiling of potentiated phospho-protein networks in cancer cells [J].
Irish, JM ;
Hovland, R ;
Krutzik, PO ;
Perez, OD ;
Bruserud, O ;
Gjertsen, BT ;
Nolan, GP .
CELL, 2004, 118 (02) :217-228
[8]   Kinomics: methods for deciphering the kinome [J].
Johnson, SA ;
Hunter, T .
NATURE METHODS, 2005, 2 (01) :17-25
[9]   A quantitative protein interaction network for the ErbB receptors using protein microarrays [J].
Jones, RB ;
Gordus, A ;
Krall, JA ;
MacBeath, G .
NATURE, 2006, 439 (7073) :168-174
[10]   The human and mouse complement of SH2 domain proteins -: Establishing the boundaries of phosphotyrosine signaling [J].
Liu, Bernard A. ;
Jablonowski, Karl ;
Raina, Monica ;
Arcé, Michael ;
Pawson, Tony ;
Nash, Piers D. .
MOLECULAR CELL, 2006, 22 (06) :851-868